Stock Taper
NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
NASDAQ
$4.69
▲ UP 1.85% (0.09)

KEY STATISTICS

Market Cap$121.62 M
52w High$12.99
52w Low$3.00
Dividend Yield
Frequency
P/E-3.82
Volume100.57K
Shares Out.25.93M

COMPANY

LEADERSHIP

Amir Farrokh Heshmatpour
CHIEF EXECUTIVE
Amir Farrokh Heshmatpour

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 26, 2025
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
5

PRICE TARGET

Target High$20.00
Target Low$13.00
Target Median$15.00
Target Consensus$16.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.
NOV
12
THU

PRICE

$4.69 ▲ UP 1.85% (+$0.09)
$4.50$4.58$4.65$4.739:30 AM10:35 AM11:39 AM12:44 PM1:49 PM2:53 PM3:58 PM4.69

About Neonc Technologies Holdings, Inc.

https://www.neonctech.com ↗

Neonc Technologies Holdings, Inc., founded in 2023 in Los Angeles, develops innovative molecular therapies like NEO100 and NEO212 for CNS diseases, with NEO100 in Phase 2a trials for glioblastoma.

INDUSTRY

Biotechnology

A PRODUCT NEONC TECHNOLOGIES HOLDINGS, INC. IS KNOWN FOR

NEO100
NEO100

NEO100, Neonc's lead intranasal drug for CNS cancers like glioblastoma, is a purified perillyl alcohol in Phase 2a trials, aiming to bypass the blood-brain barrier and advance treatment options.

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

DIRECTOR, 10 PERCENT OWNER, OFFICER: PRESIDENT
Heshmatpour Amir F
Purchase · 6.0K shares
2025-11-24
DIRECTOR, 10 PERCENT OWNER, OFFICER: PRESIDENT
Heshmatpour Amir F
Purchase · 4.0K shares
2025-11-21
DIRECTOR, 10 PERCENT OWNER, OFFICER: PRESIDENT
Heshmatpour Amir F
Purchase · 20.0K shares
2025-11-21
DIRECTOR
CHIANG MING-FU (ALAN)
· —
2025-11-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
IVVD$2.40COMPARE
OBIO$4.57COMPARE
IVA$4.49COMPARE
OABI$2.17COMPARE
TARA$6.00COMPARE
SLS$2.00COMPARE
MDWD$19.29COMPARE
CDXS$1.70COMPARE